165 related articles for article (PubMed ID: 37672062)
1. COVID-19 and MIS-C treatment in children-results from an international survey.
Donà D; Minotti C; Masini T; Penazzato M; Van Der Zalm MM; Judd A; Giaquinto C; Lallemant M;
Eur J Pediatr; 2023 Nov; 182(11):5087-5093. PubMed ID: 37672062
[TBL] [Abstract][Full Text] [Related]
2. Early Treatments of Fragile Children with COVID-19-Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study.
Minotti C; Mengato D; De Pieri M; Trivellato S; Francavilla A; Di Chiara C; Liberati C; Mattera R; Biffi A; Giaquinto C; Venturini F; Donà D
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680232
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Awareness and Experience of Using off-label Drugs by Doctors of Clinical Specialties.
Drapkina OM; Shepel RN; Martsevich SY; Kutishenko NP; Berns SA; Bulgakova ES; Orlov DO; Belkin IA
Kardiologiia; 2021 May; 61(5):41-50. PubMed ID: 34112074
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Mukattash T; Hawwa AF; Trew K; McElnay JC
Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
[TBL] [Abstract][Full Text] [Related]
8. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
9. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
[TBL] [Abstract][Full Text] [Related]
10. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists.
Janda A; Schuetz C; Canna S; Gorelik M; Heeg M; Minden K; Hinze C; Schulz A; Debatin KM; Hedrich CM; Speth F
Rheumatol Int; 2021 May; 41(5):911-920. PubMed ID: 33683393
[TBL] [Abstract][Full Text] [Related]
12. Perceptions and attitudes towards off-label dispensing for pediatric patients, a study of hospital based pharmacists in Jordan.
Mukattash TL; Alzoubi KH; Abuirjie AM; Jarab AS; Abu Farha RK; Nusair MB; McElnay JC
Saudi Pharm J; 2018 Jan; 26(1):20-24. PubMed ID: 29379329
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients.
Bellino S
Ann Med; 2022 Dec; 54(1):2856-2860. PubMed ID: 36259490
[TBL] [Abstract][Full Text] [Related]
14. Updated Guidance on Use and Prioritization of Monoclonal Antibody Therapy for Treatment of COVID-19 in Adolescents.
Wolf J; Abzug MJ; Anosike BI; Vora SB; Waghmare A; Sue PK; Olivero RM; Oliveira CR; James SH; Morton TH; Maron GM; Young JL; Orscheln RC; Schwenk HT; Bio LL; Willis ZI; Lloyd EC; Hersh AL; Huskins CW; Soma VL; Ratner AJ; Hayes M; Downes K; Chiotos K; Grapentine SP; Wattier RL; Lamb GS; Zachariah P; Nakamura MM
J Pediatric Infect Dis Soc; 2022 May; 11(5):177-185. PubMed ID: 35107571
[TBL] [Abstract][Full Text] [Related]
15. [COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey].
Janda A; Schuetz C; Heeg M; Minden K; Hedrich CM; Kallinich T; Hinze C; Schulz A; Speth F
Z Rheumatol; 2020 Sep; 79(7):710-717. PubMed ID: 32809050
[TBL] [Abstract][Full Text] [Related]
16. Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey.
Denburg AE; Fundytus A; Khan MS; Howard SC; Antillon-Klussmann F; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
JCO Glob Oncol; 2022 Jun; 8():e2200034. PubMed ID: 35749676
[TBL] [Abstract][Full Text] [Related]
17. Pediatric neurosurgical workforce, access to care, equipment and training needs worldwide.
Dewan MC; Baticulon RE; Rattani A; Johnston JM; Warf BC; Harkness W
Neurosurg Focus; 2018 Oct; 45(4):E13. PubMed ID: 30269579
[TBL] [Abstract][Full Text] [Related]
18. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review.
Wang Z; Zhao S; Tang Y; Wang Z; Shi Q; Dang X; Gan L; Peng S; Li W; Zhou Q; Li Q; Mafiana JJ; Cortés RG; Luo Z; Liu E; Chen Y
Eur J Pediatr; 2022 May; 181(5):2135-2146. PubMed ID: 35192051
[TBL] [Abstract][Full Text] [Related]
19. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
